Articles
Counterpoint: PhRMA scores a win for the industry in D.C.

Counterpoint: PhRMA scores a win for the industry in D.C.

In response to a recent article looking at US healthcare reform, Kitty Holman suggests that it’s not all bad news for the pharma industry. Although it isn't exactly certain how pharmaceutical companies will be affected by recent healthcare legislation...

Articles
What are IDEAs made of: Audiences

What are IDEAs made of: Audiences

So the group of KOLs love your product and it’s set to be a huge success, right? But what if they’re not right audience, Mike Rea asks in this week’s WAIMO. Following down the path of influence for even one RTI antibiotic prescribing decision can be a Poirot-like exercise...

Articles
Rethinking patient noncompliance (Part 2)

Rethinking patient noncompliance (Part 2)

Following on from the first article, part 2 of this series sees Allan Showalter exploring some possible solutions to addressing the issues of patient noncompliance. Part 1 of "Rethinking patient noncompliance" focused on the reasons noncompliance...

Sales & Marketing

Sales & Marketing
Solution Spotlight: BrandPRO Biopharma
Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Digital

Market Access

Editor's Picks

  1. UK budget includes £1bn biopharma investment package
  2. HHS doubles down on controversial peptides plan
  3. Lilly's triple G overpowers Ozempic in diabetes trial
  4. UK puts £100m into "world-first" AI biosecurity facility
  5. US gives $99m for Ebola jab project, as cases spread in Africa

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more